Article
Multiple Highly Methylated CpG Sites as Potential Epigenetic Markers for the Diagnosis of Prostate Cancer
2024-12-23
Abstract excerpt
Prostate cancer represents the second most frequently diagnosed malignant tumour in males. Serum PSA is used as a screening tool for prostate cancer. However, there are limitations to this approach due to the number of false positives it generates, which can result in overdiagnosis and over-treatment. The objective of this study was to identify accurate DNA methylation markers for the diagnosis of prostate cancer....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 46416707-1a23-5f73-a764-bd58737b3a07
- DOI
- 10.20944/preprints202412.2005.v1
